---  
layout: startup_page  
title: "Enterprise Therapeutics"  
id: "enterprisetherapeutics.com"  
permalink: "/enterprisetherapeuticsenterprisetherapeutics.com01302024/"  
website: "https://www.enterprisetherapeutics.com/"  
funding_round: "Series B"  
funding_amount: "$33.1M"  
investors: "Panakes Partners, Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital, IP Group"  
about: "Enterprise Therapeutics is a biopharmaceutical company focused on discovering and developing novel therapies for respiratory diseases. Their lead program, ETD001, is a first-in-class ENaC blocker targeting cystic fibrosis, aiming to improve lung function and reduce morbidity. The company's pipeline includes other disease-modifying therapies targeting mucus congestion in conditions like COPD and severe asthma."  
markets: "Biopharmaceuticals, Respiratory Disease Therapeutics, Health Care, Health Diagnostics, Therapeutics, Biotechnology, Drug Discovery"  
hq: "Brighton, East Sussex, United Kingdom"  
founded_year: "2014"  
linkedin: "https://uk.linkedin.com/company/enterprise-therapeutics"  
twitter: "https://twitter.com/enterprisethera"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/enterprise-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/108262-63"  

date_display: "30-Jan-2024"  
date: "2024-01-30"

# SEO Optimization  
meta_title: "Enterprise Therapeutics - Series B Funding ($33.1M)"  
meta_description: "Enterprise Therapeutics, Enterprise Therapeutics is a biopharmaceutical company focused on discovering and developing novel therapies for respiratory diseases. Their lead prog..."  
meta_keywords: "Enterprise Therapeutics, Biopharmaceuticals, Respiratory Disease Therapeutics, Health Care, Health Diagnostics, Therapeutics, Biotechnology, Drug Discovery, Series B funding"  
canonical_url: "https://startup.projectstartups.com/enterprisetherapeuticsenterprisetherapeutics.com01302024/"  
---